Nucleoprotein antigen (NP)

Nucleoprotein (NP) is a structural protein encoded by many RNA viruses, responsible for binding and protecting the viral genome, forming ribonucleoprotein (RNP) complexes essential for the viral life cycle[1][2][3][8]. NP plays a central role in encapsidating viral RNA, facilitating its replication and transcription, and participating in virion assembly[1][3]. It is one of the most abundant and conserved viral proteins in negative-strand RNA viruses. As a highly immunogenic protein, NP acts as a major antigen for host immune responses, eliciting both antibody and T-cell-mediated immunity[2][3]. Because NP is relatively conserved within virus families, it is targeted for broad-spectrum diagnostics and is under investigation as a potential universal vaccine target for influenza and other viruses[2]. Small-molecule inhibitors, such as nucleozin (for influenza), can disrupt NP-NP interactions, impeding viral replication[4]. The clinical utility and structure of NP vary between viruses, so detailed consideration of the specific viral context is required for therapeutic or diagnostic applications. Note: - If you need structured information for a specific virus (e.g., "Influenza A virus nucleoprotein" or "SARS-CoV-2 nucleocapsid protein"), the entries should be customized for that protein, as properties—especially regarding drug interactions, disease roles, and immunogenicity—differ significantly[2][3][8]. - "Nucleoprotein antigen" is not adequate as a unique, standardized molecular target name.

Other names

NucleoproteinNPnucleocapsid protein (N, especially in coronaviruses and many RNA viruses)

Inhibitors may prevent NP oligomerization or RNA binding, disrupting viral replication[4] Induction of antibody-mediated viral clearance or cellular immune response via recognition of NP as an antigen[3]